University at Buffalo: After Treatment With Semaglutide, Newly Diagnosed Type 1 Diabetes Patients Needed Little or No Insulin
September 07, 2023
September 07, 2023
BUFFALO, New York, Sept. 7 (TNSres) -- The University at Buffalo (State University of New York) issued the following news release:
* * *
Study author says it "could possibly be the most dramatic change in treating Type 1 diabetes since the discovery of insulin in 1921," if findings are borne out in larger studies over extended follow-up periods
* * *
Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozemp . . .
* * *
Study author says it "could possibly be the most dramatic change in treating Type 1 diabetes since the discovery of insulin in 1921," if findings are borne out in larger studies over extended follow-up periods
* * *
Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozemp . . .